Accumulating evidence has revealed that SIRT7 exerts oncogenic effect in various malignancies including prostate cancer, hepatocellular carcinoma, and cholangiocarcinoma [12, 29, 30]. Here, SIRT7 is linked to Familial prostate cancer.